Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • HEAVY-CHAIN DISEASES AND MYELOMA-ASSOCIATED FANCONI SYNDROME: AN UPDATE

    Roberto Ria, Franco Dammacco, Angelo Vacca
    e2018011
    2018-01-01
    https://doi.org/10.4084/mjhid.2018.011
    5983
    PDF: 1678
    HTML: 1443
  • CURRENT STRATEGIES FOR THE DETECTION OF MINIMAL RESIDUAL DISEASE IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA

    Juliana Maria Camargos Rocha, Sandra Guerra Xavier, Marcelo Eduardo Lima Souza, Juliana Godoy Assumpção, Mitiko Murao, Benigna Maria Oliveira
    e2016024
    2016-04-10
    https://doi.org/10.4084/mjhid.2016.024
    4690
    PDF: 1370
    HTML: 4900
  • MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.

    Maria Ilaria Del Principe
    e2016052
    2016-10-20
    https://doi.org/10.4084/mjhid.2016.052
    5064
    PDF: 1341
    HTML: 1928
    Untitled: 195
    Untitled: 191
  • Bone marrow involvement in a patient with alpha heavy chain disease:Response to tetracycline treatment

    Zahit Bolaman, Irfan Yavasoglu, Gokhan Sargin, Gurhan Kadikoylu, Firuzan Kacar Doger
    e2012034
    2012-05-07
    https://doi.org/10.4084/mjhid.2012.034
    1250
    PDF: 1039
    HTML: 3416
  • NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?

    Alessandro Corso, Silvia Mangiacavalli
    e2017053
    2017-08-18
    https://doi.org/10.4084/mjhid.2017.053
    3336
    PDF: 1736
    HTML: 1149
  • PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma

    Ugo Testa; Giuseppe G.M. Leone
    e2025005
    2024-12-31
    https://doi.org/10.4084/MJHID.2025.005
    2530
    HTML: 296
    PDF: 929
  • ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA

    Luca Laurenti, Michela Tarnani, Patrizia Chiusolo, Federica Sorà, Simona Sica
    e2010026
    2010-08-31
    https://doi.org/10.4084/mjhid.2010.026
    1431
    PDF: 833
    HTML: 1025
  • POEMS SYNDROME: AN UPDATE

    Andrea Nozza
    e2017051
    2017-09-01
    https://doi.org/10.4084/mjhid.2017.051
    3418
    PDF: 1686
    HTML: 1768
  • Gamma heavy chain disease associated with T-cell large granular lymphocyte lymphoproliferative disorder: case report and literature review.

    Maria Laura Bisegna, Maria Assunta Limongiello, Stefano Fiori, Maria Stefania De Propris, Irene Della Starza, Stefania Trasarti
    e2023010
    2023-01-01
    https://doi.org/10.4084/MJHID.2023.010
    1055
    PDF: 973
    HTML: 466
  • The THE PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW: PART 2-FOCUS ON THERAPY

    Michele Bibas
    e2024015
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.015
    2319
    PDF: 1753
    HTML: 949
  • HHVs AND LYMPHOPROLIFERATIVE DISORDERS

    C Quadrelli, P Barozzi, G Riva, Mario Luppi
    e2011043
    2011-10-24
    https://doi.org/10.4084/mjhid.2011.043
    1466
    PDF: 844
    HTML: 3129
  • IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS

    Alana Kennedy-Nasser, Catherine Bollard, Helen Heslop
    e2009010
    2009-11-13
    https://doi.org/10.4084/mjhid.2009.010
    1250
    PDF: 616
    HTML: 6876
  • EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES

    Pietro Tralongo, Arianna Bakacs, Luigi Maria Larocca
    e2024042
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.042
    4537
    PDF: 1759
    HTML: 1171
  • CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,

    Ugo Testa, Giuseppe Leone, Elvira Pelosi, Dr. Germana Castelli, Prof. Hohaus
    e2023066
    2023-10-30
    https://doi.org/10.4084/MJHID.2023.066
    3816
    PDF: 1514
    HTML: 321
  • CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY

    Maria Ilaria Del Principe, Luca Maurillo, Francesco Buccisano, Giuseppe Sconocchia, Mariagiovanna Cefalo, Giovanna De Santis, Ambra Di Veroli, Concetta Ditto, Daniela Nasso, Massimiliano Postorino, Marco Refrigeri, Cristina Attrotto, Giovanni Del Poeta, Sergio Amadori, Adriano Venditti
    e2014075
    2014-11-01
    https://doi.org/10.4084/mjhid.2014.075
    4258
    PDF: 1976
    HTML: 5498
    Table 1: 226
  • IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS

    Efterpi Kostareli, Maria Gounari, Andreas Agathangelidis, Kostas Stamatopoulos
    e2012052
    2012-08-09
    https://doi.org/10.4084/mjhid.2012.052
    3131
    PDF: 903
    HTML: 7293
    Kost Fig1: 206
    Kost Fig 2: 194
    Kost Fig3: 196
    Kost Fig 4: 209
    Kost Fig5: 209
    Kost fig 6: 194
  • Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA

    Bhavya S Doshi, Valder R Arruda, Valder R Arruda
    e2020069
    2020-09-08
    https://doi.org/10.4084/mjhid.2020.069
    2178
    PDF: 1955
    HTML: 521
  • PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations

    Michele Bibas
    e2024007
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.007
    3665
    PDF: 2575
    HTML: 1563
  • PATHOBIOLOGY OF HODGKIN LYMPHOMA

    Claudio Agostinelli, Stefano Pileri
    e2014040
    2014-06-05
    https://doi.org/10.4084/mjhid.2014.040
    3331
    PDF: 1494
    HTML: 5960
    Fig1-Ag-Pil: 250
    Ag-Pil Fig.2: 250
  • WALDENSTRÖM MACROGLOBULINEMIA - A STATE-OF-THE-ART REVIEW: PART 1: EPIDEMIOLOGY, PATHOGENESIS, CLINICOPATHOLOGIC CHARACTERISTICS, DIFFERENTIAL DIAGNOSIS, RISK STRATIFICATION, AND CLINICAL PROBLEMS

    Michele Bibas, Shayna Sarosiek, Jorge J. Castillo
    e2024061
    2024-06-29
    https://doi.org/10.4084/MJHID.2024.061
    3008
    PDF: 3302
    HTML: 651
  • IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA? MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA

    Ugo Testa, Prof. Leone, Dr. Elvira Pelosi, Dr. Germana Castelli, Prof, Valerio De Stefano
    e2024044
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.044
    2612
    PDF: 1206
    HTML: 151
  • THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION

    Sumit Dahal, Smrity Upadhyay, Rashmi Banjade, Prajwal Dhakal, Navin Khanal, Vijaya Raj Bhatt
    e2017019
    2017-03-01
    https://doi.org/10.4084/mjhid.2017.019
    4260
    PDF: 1998
    HTML: 1946
  • HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION

    Francesco Lo-Coco, Laura Cicconi
    e2011067
    2011-12-21
    https://doi.org/10.4084/mjhid.2011.067
    3253
    PDF: 1137
    HTML: 1872
  • “IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”

    Sara Martinelli, Antonio Cuneo, Gian Matteo Rigolin
    e2016047
    2016-10-15
    https://doi.org/10.4084/mjhid.2016.047
    4051
    PDF: 1078
    HTML: 3893
    Untitled: 185
    Cneo. Fig.1: 122
    Untitled: 114
    Untitled: 142
    Untitled: 147
  • IRON METABOLISM IN THALASSEMIA AND SICKLE CELL DISEASE

    Raffaella Mariani, Paola Trombini, Matteo Pozzi, Alberto Piperno
    e2009006
    2009-10-27
    1671
    PDF: 667
    HTML: 43937
  • CARDIAC FUNCTION AND IRON CHELATION IN THALASSEMIA MAJOR AND INTERMEDIA: A REVIEW OF THE UNDERLYING PATHOPHYSIOLOGY AND APPROACH TO CHELATION MANAGEMENT

    Athanasios Aessopos, Vasilios Berdoukas
    e2009002
    2009-07-18
    1632
    PDF: 492
    HTML: 1558
  • EARLY APPLICATION OF HIGH CUT-OFF HAEMODYALISIS FOR DE-NOVO MYELOMA NEPHROPATHY IS ASSOCIATED WITH LONG-TERM DIALYSIS-INDEPENDENCY AND RENAL RECOVERY

    Alhossain A. Khalafallah, Sie Wuong Loi, Sarah Love, Muhajir B. Mohamed, Rose Mace, Ramy Khalil, Miriam Girgs, Rajesh Raj, Mathew Mathew
    e2013007
    2013-01-02
    https://doi.org/10.4084/mjhid.2013.007
    1410
    PDF: 680
    HTML: 2543
    cover letter: 211
  • RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM

    Ugo Testa, Elvira Pelosi, Germana Castelli, Giuseppe Leone
    e2023062
    2024-06-29
    https://doi.org/10.4084/MJHID.2024.062
    1326
    PDF: 1101
    HTML: 245
  • REAL WORLD MULTIPLE MYELOMA REGISTRY FROM JORDAN, A DEVELOPING COUNTRY.

    Abdalla Awidi, Farah Qasem, A'sem Abu-Qamar, Batool Aqel, Rand Aladayleh, Ilham Alteerah, Ahmad Magableh, , Hisham Bawa”neh, Feras Al-fararjeh
    e2022031
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.031
    1354
    PDF: 774
    HTML: 413
  • POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE

    Daniela Capello, Gianluca Gaidano
    e2009018
    https://doi.org/10.4084/mjhid.2009.018
    1351
    PDF: 481
    HTML: 18620
    Figure 1: 179
    Figure 2: 160
    Figure 3: 177
    Figure 4: 215
    Figure 5: 188
  • Therapy Outcome of a T-Cell-Rich-B-Cell Lymphoma (TCRBCL) Patient with Rituximab-CHOP in Ibadan, Nigeria: a Case Report.

    John Ayodele Olaniyi
    e2011008
    2011-03-14
    https://doi.org/10.4084/mjhid.2011.008
    2462
    PDF: 606
    HTML: 1196
  • CLASSIC KSHV/HHV-8-POSITIVE PRIMARY EFFUSION LYMPHOMA (PEL): A SYSTEMATIC REVIEW AND META-ANALYSIS OF CASE REPORTS

    Ilaria Cozzi, Giovanni Rossi, Emma Rullo, Valeria Ascoli
    e2022020
    2022-02-27
    https://doi.org/10.4084/MJHID.2022.020
    1625
    PDF: 996
    HTML: 422
  • CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA

    Alessandro Bartoloni, Lorenzo Zammarchi
    e2012026
    2012-05-04
    https://doi.org/10.4084/mjhid.2012.026
    8191
    PDF: 4373
    HTML: 7543
1 - 33 of 33 items
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.